Literature DB >> 23786336

Statistical estimation & inference of cell counts from ELISPOT limiting dilution assays.

Hongmei Yang1, David J Topham, Jeanne Holden-Wiltse, Hulin Wu.   

Abstract

The ELISPOT assay is often used for cell count determination in immunological studies. Automated methods are needed to estimate cell concentrations from spot counts obtained from the assay. Three major distributions are assumed for observational cell counts. For each assumed distribution, individual least squares (LS)/ maximum likelihood and/or individual robust least squares (RLS) are applied for parameter estimation. Distributions of study endpoints (derived variables), defined as percentages of antigen-specific memory cell per total immunoglobulin G (IgG), are investigated to provide a basis for hypothesis testing. We show, under some weak conditions, that the distribution of endpoint estimates across subjects is approximately the same within a group. Thus, the t -test or the Wilcoxon Rank Sum test can be applied to detect group differences. These methods are compared through simulations and application to real data.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23786336      PMCID: PMC3803109          DOI: 10.1080/10543406.2013.790645

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  8 in total

1.  Statistical analysis of radioligand assay data.

Authors:  D Rodbard; G R Frazier
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials.

Authors:  Michael G Hudgens; Steven G Self; Ya-Lin Chiu; Nina D Russell; Helen Horton; M Juliana McElrath
Journal:  J Immunol Methods       Date:  2004-05       Impact factor: 2.303

3.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.

Authors:  Shane Crotty; Rachael D Aubert; John Glidewell; Rafi Ahmed
Journal:  J Immunol Methods       Date:  2004-03       Impact factor: 2.303

4.  Radioligand Assay.

Authors:  D J Finney
Journal:  Biometrics       Date:  1976-12       Impact factor: 2.571

5.  Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials.

Authors:  Zoe Moodie; Yunda Huang; Lin Gu; John Hural; Steven G Self
Journal:  J Immunol Methods       Date:  2006-08-15       Impact factor: 2.303

Review 6.  Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays.

Authors:  D Rodbard
Journal:  Clin Chem       Date:  1974-10       Impact factor: 8.327

7.  Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.

Authors:  Nega Ali Goji; Carrie Nolan; Heather Hill; Mark Wolff; Diana L Noah; Tracy B Williams; Thomas Rowe; John J Treanor
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

8.  A four-parameter logistic model for estimating titers of functional multiplexed pneumococcal opsonophagocytic killing assay.

Authors:  Deli Wang; Robert L Burton; Moon H Nahm; Seng-Jaw Soong
Journal:  J Biopharm Stat       Date:  2008       Impact factor: 1.051

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.